Leading the way
The industry's best and brightest people are part of the Vertex team.聽Collectively, their聽decades of experience聽helped us聽launch four breakthrough medicines聽within seven years聽and will guide the way forward as we work toward聽bringing more transformative medicines to people living with serious diseases around the world.聽
![A hand holds a marker writing on a piece of glass](/sites/global/files/styles/hero_title_img_v6_desktop/public/oc_lead_hero.jpg?itok=BZnFcoel)
The industry's best and brightest people are part of the Vertex team.聽Collectively, their聽decades of experience聽helped us聽launch four breakthrough medicines聽within seven years聽and will guide the way forward as we work toward聽bringing more transformative medicines to people living with serious diseases around the world.聽
Leader spotlight
Reshma Kewalramani, M.D., FASN
Chief Executive Officer and President
鈥淎t our core, we鈥檙e a company focused on transforming serious diseases through innovation and great science. We鈥檝e assembled the teams, tools and technologies to deliver on our R&D strategy and to deliver for patients.鈥
![Reshma Kewalramani in a lab coat](/sites/global/files/styles/featured_block_v5_desktop/public/oc_leadership_reshmabw.jpg?itok=M0DN_f-o)
尝别补诲别谤蝉丑颈辫听
Our diverse聽leadership team聽includes industry luminaries and disrupters聽all working toward聽discovering tomorrow鈥檚 transformative medicines.聽
Board of Directors
Our Board has been a source of stability and experience that has helped guide our growth from a small research startup to a global S&P 500 company that continues to execute on its mission of investing in scientific innovation to create transformative medicines for people with serious diseases in specialty markets.聽
Four of our 11 (36%) Board Directors are from racial and ethnic minority groups, and five of 11 (45%) are women聽鈥 these diverse perspectives combined with decades of experience will be an important source of guidance.聽
Member
Chair
Lead Independent Director